Effimune's Merger

Effimune raised a round of funding on February 24, 2016. Investors include OSE Pharma.

Effimune conducts research and development of drug candidates for transplantation and immune-mediated diseases. The Company specializes in the development of first-in-class biological drug candidates …

Articles about Effimune's Merger: